Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stian Foss

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|December 4, 2019
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringesHeidrun Elisabeth Lode, Torleif Tollefsrud Gjølberg, Stian Foss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2015
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector FunctionsAlgirdas Grevys, Malin Bern, Stian Foss, et al.
Science Immunology|April 29, 2022
Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hingeStian Foss, Alexandra Jonsson, Maria Bottermann, et al.
International Journal of Retina and Vitreous|November 8, 2023
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding propertiesØystein Kalsnes Jørstad, Stian Foss, Torleif Tollefsrud Gjølberg, et al.
Scientific Reports|January 25, 2013
Selection of nanobodies that target human neonatal Fc receptorJan Terje Andersen, Maria Gonzalez-Pajuelo, Stian Foss, et al.
Plos Pathogens|August 5, 2020
Intracellular neutralisation of rotavirus by VP6-specific IgGSarah L Caddy, Marina Vaysburd, Mark Wing, et al.
The Journal of Biological Chemistry|April 26, 2014
Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodiesKine Marita Knudsen Sand, Bjørn Dalhus, Gregory J Christianson, et al.
Communications Biology|August 18, 2022
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-lifeTorleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2016
TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization ActivityStian Foss, Ruth E Watkinson, Algirdas Grevys, et al.
Immunohorizons|January 25, 2022
Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal AntibodyTrude V Mørtberg, Huiying Zhi, Gestur Vidarsson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|December 4, 2019
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringesHeidrun Elisabeth Lode, Torleif Tollefsrud Gjølberg, Stian Foss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2015
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector FunctionsAlgirdas Grevys, Malin Bern, Stian Foss, et al.
Science Immunology|April 29, 2022
Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hingeStian Foss, Alexandra Jonsson, Maria Bottermann, et al.
International Journal of Retina and Vitreous|November 8, 2023
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding propertiesØystein Kalsnes Jørstad, Stian Foss, Torleif Tollefsrud Gjølberg, et al.
Scientific Reports|January 25, 2013
Selection of nanobodies that target human neonatal Fc receptorJan Terje Andersen, Maria Gonzalez-Pajuelo, Stian Foss, et al.
Plos Pathogens|August 5, 2020
Intracellular neutralisation of rotavirus by VP6-specific IgGSarah L Caddy, Marina Vaysburd, Mark Wing, et al.
The Journal of Biological Chemistry|April 26, 2014
Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodiesKine Marita Knudsen Sand, Bjørn Dalhus, Gregory J Christianson, et al.
Communications Biology|August 18, 2022
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-lifeTorleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2016
TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization ActivityStian Foss, Ruth E Watkinson, Algirdas Grevys, et al.
Immunohorizons|January 25, 2022
Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal AntibodyTrude V Mørtberg, Huiying Zhi, Gestur Vidarsson, et al.
Pageof 4